Study of Efficacy, Safety & Tolerability of CMK389 in Patients With

See also
Status	Clinical Trial	Phase
Terminated	`NCT00262132` - Mycophenolate for Pulmonary Sarcoidosis	Phase 3
Recruiting	`NCT05415137` - Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis	Phase 3
Recruiting	`NCT00001532` - Role of Genetic Factors in the Development of Lung Disease
Completed	`NCT04318392` - Breath Analysis in Patients With Suspected Sarcoidosis: The VOCs-IS Study
Active, not recruiting	`NCT03755245` - Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis	N/A
Completed	`NCT01587001` - The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis	N/A
Recruiting	`NCT05890729` - A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis	Phase 1/Phase 2
Recruiting	`NCT02824419` - Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis	Phase 2/Phase 3
Recruiting	`NCT06205121` - Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis	Phase 2
Completed	`NCT02200146` - Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).	Phase 3
Terminated	`NCT01732211` - A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis	Phase 2
Enrolling by invitation	`NCT06169397` - An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis	Phase 2
Active, not recruiting	`NCT05368883` - Comparison of the Effects of One-Legged and Two-Legged Exercise Training on Exercise Capacity and Fatigue in Patients With Sarcoidosis	N/A
Not yet recruiting	`NCT05247554` - Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis	Phase 3
Completed	`NCT03599414` - CASPA: CArdiac Sarcoidosis in PApworth
Recruiting	`NCT02188017` - Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)	Phase 4
Recruiting	`NCT06113991` - Study Comparing Chronic Beryllium Disease to Pulmonary Sarcoidosis
Completed	`NCT01169038` - Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis	Phase 1
Completed	`NCT00701207` - Study of Nicotine Patches in Patients With Sarcoidosis	Early Phase 1
Completed	`NCT03824392` - Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis	Phase 1/Phase 2

NCT number	NCT04064242
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	September 23, 2020
Completion date	December 12, 2023

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms